Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

PFOS exposure disrupts hormone levels and enzyme activities in juvenile frogs, affecting males and females differently.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

5-Bromo-3,4-dihydroxybenzaldehyde could potentially help hair growth by activating certain cell pathways and inhibiting others.

TrichoFoam™ effectively delivers multiple hair loss treatments, maintaining their stability and effectiveness.

Certain chemical changes to cortisol and progesterone can increase or decrease their ability to inhibit hair growth.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

Four-amino acid part makes enzyme sensitive to finasteride.

New progesterone-based compounds can block male hormones.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Three methods accurately measure finasteride in tablets using dyes and bromate-bromide.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

A new method using NBD-CL can accurately and precisely measure finasteride in medicine, and could be used regularly for quality control in the industry.

Potential new drugs for treating PCOS were identified.

Reducing 5α-reductase activity helps endometrial cells differentiate, aiding pregnancy.